2018 Disruptor 50: No. 46 Auris Health
May 22, 2018 at 06:00 AM EDT
Auris received FDA approval in March for its Monarch Platform, which uses more flexible robotics during endoscopic procedures, to accurately diagnose lung cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.